Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL614579 | 0.72 | ALDH1A1 (0.33) | TDP1TSHRALDH1A1 | |
| SCHEMBL705895 | 0.69 | TDP1 (0.31) | TDP1TSHRALDH1A1 | |
| SCHEMBL1803047 | 0.69 | TDP1 (0.31) | TDP1TSHRALDH1A1 | |
| SCHEMBL180305 | 0.67 | ALDH1A1 (0.36) | TDP1TSHRALDH1A1 | |
| SCHEMBL180050 | 0.65 | — | — | |
| SCHEMBL23706467 | 0.64 | ALDH1A1 (0.33) | TDP1TSHRALDH1A1 | |
| SCHEMBL190678 | 0.64 | ALDH1A1 (0.33) | TDP1TSHRALDH1A1 | |
| Fluoride SCHEMBL16568734 | 0.64 | ALDH1A1 (0.33) | TDP1TSHRALDH1A1 | |
| SCHEMBL426245 | 0.64 | ALDH1A1 (0.33) | TDP1TSHRALDH1A1 | |
| SCHEMBL703161 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3019511-B1 | IMMOBILIZED METATHESIS TUNGSTEN CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | XIMO AG (CH) | 2019-01-02 | — | — | EP | disclosed |
| US-20160168283-A1 | CHROMIUM(III) SILICATE CATALYSTS SUITABLE FOR PE SYNTHESIS | ETH ZURICH (CH) | 2016-06-16 | — | — | US | disclosed |
| EP-3022232-A1 | CHROMIUM(III) SILICATE CATALYSTS SUITABLE FOR PE SYNTHESIS | ETH Zurich (CH) | 2016-05-25 | — | — | EP | disclosed |
| EP-3019511-A1 | IMMOBILIZED METATHESIS TUNGSTEN CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | XiMo AG (CH) | 2016-05-18 | — | — | EP | disclosed |
| US-20160122375-A1 | IMMOBILIZED METATHESIS TUNGSTEN CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | VERBIO VEREINIGTE BIOENERGIE AG (DE) | 2016-05-05 | — | — | US | disclosed |
| WO-2015007828-A1 | CHROMIUM(III) SILICATE CATALYSTS SUITABLE FOR PE SYNTHESIS | ETH ZURICH (CH) | 2015-01-22 | — | — | WO | disclosed |
| EP-2826795-A1 | Chromium(III) silicate catalysts suitable for PE synthesis | ETH Zurich (CH) | 2015-01-21 | — | — | EP | disclosed |
| WO-2015003815-A1 | IMMOBILIZED METATHESIS TUNGSTEN CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | XIMO AG (CH) | 2015-01-15 | — | — | WO | disclosed |
| US-20040242782-A1 | Rubber composition and vulcanized rubber | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160122375-A1 | IMMOBILIZED METATHESIS TUNGSTEN CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | NR1H3, NR1H2, RCOR3 | TDP1 3829/4885TSHR 71/4885ALDH1A1 3029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.